Bone Regeneration Made Possible With Stem Cells

Epibone creates precisely measured scaffolding for stem cells to recreate damaged bone.

The New York-based startup Epibone intends to begin human testing on a procedure that will utilize stem cells to regenerate living bone tissue.  The researchers, originally from Columbia University, will apply autologous [the patient’s own] stem cells to nanofiber scaffolding of the desired size and shape and direct the stem cells to differentiate into a physical and genetic replica of the patient’s own bone. Continue reading

Osteoarthritis Stem Cell Treatment in Clinical Trial

The transplantation of stem cells into areas affected by osteoarthritis allow lost cartilage tissue to regenerate.

In recent clinical trials, researchers at the National University of Ireland Galway have successfully utilized adult stem cells to treat patients with osteoarthritis.  The treatment involves recovering the patients’ own [autologous] stem cells and then injecting the stem cells into cartilage to stimulate the regeneration of lost tissue. Continue reading

Leg Injuries Healed With Patient’s Stem Cell Therapy.

A new stem cell therapy allows patients to regrow leg muscle after traumatic injuries.

A research team led by Stephen Badylak at the University of Pittsburgh has used the patient’s own stem cells to help them recover from injuries in which over 50% of their leg muscle was lost. First, they implanted a biological scaffold into the wound.  Then, the patients underwent aggressive physical therapy, which directed the recruitment of stem cells to the site of injury to rebuild properly aligned muscle tissue. By the end of the treatment, patients exhibited muscle regrowth and at least a 20% increase in leg strength. Continue reading

Autologous Stem Cell Treatment for Peripheral Arterial Disease [PAD]

Peripheral Arterial Disease leg schematic

University Hospital’s Case Medical Center researchers are to begin evaluating the ability of the patient’s own stem cells [autologous stem cells] to prevent leg amputations in peripheral arterial disease.  PAD effects more than 5 million adults in the US alone.  Dr. Vik Kashyap, the leading researcher, explained, “This trial offers an opportunity to save a patient’s leg when there are no remaining options to improve blood supply.”

Continue reading